Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$867,554
+$779,343 QoQ
Shares Held
122,536
+1014.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 164 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names. GRFS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,031,961 | $262,087,135 | |
| 2 | ABBV |
AbbVie Inc.
|
702,907 | $176,879,517 | |
| 3 | MRK |
Merck & Co., Inc.
|
798,048 | $102,549,168 | |
| 4 | LLY |
ELI LILLY & Co
|
38,616 | $46,317,192 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
741,187 | $42,707,194 | |
| 6 | GSK |
GSK plc
|
603,902 | $31,656,542 | |
| 7 | NVS |
Novartis AG
|
89,587 | $14,040,074 | |
| 8 | NVO |
Novo Nordisk A S
|
148,940 | $7,140,183 |
All Filings in GRFS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $867,554 | 122,536 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $88,211 | 10,999 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $201,948 | 20,276 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $197,033 | 26,483 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,850,050 | 208,339 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $78,824 | 11,800 | Shares | Defined | 2024-05-13 | |
| 2022-09-30 | $204,425 | 33,186 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $294,125 | 25,182 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||